ARROWHEAD PHARMACEUTICALS IN

Ticker: ARWR CUSIP: 04280A100 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 123,855 Value ($000) $8,223 Avg Close $49.01 Range $34.38 - $72.36
Q3 2025
Shares 1,436,840 Value ($000) $49,557 Avg Close $21.98 Range $14.30 - $34.61
Q2 2025
Shares 2,155,998 Value ($000) $34,065 Avg Close $14.35 Range $9.57 - $17.49
Q1 2025
Shares 59,760 Value ($000) $761 Avg Close $18.18 Range $12.14 - $21.84
Q4 2024
Shares 86,633 Value ($000) $1,629 Avg Close $20.59 Range $17.05 - $27.34
Q3 2023
Shares 107,648 Value ($000) $2,893 Avg Close $30.63 Range $26.04 - $36.43
Q2 2023
Shares 301,041 Value ($000) $10,735 Avg Close $34.48 Range $24.64 - $42.48
Q1 2022
Shares 182,799 Value ($000) $8,408 Avg Close $49.51 Range $38.89 - $70.09
Q2 2021
Shares 250,380 Value ($000) $20,736 Avg Close $74.45 Range $60.52 - $93.66
Q4 2020
Shares 287,817 Value ($000) $22,084 Avg Close $63.95 Range $42.44 - $86.75